ELUT
Elutia Inc.
Price Chart
Latest Quote
$1.06
+0.07 (+6.92%)
Current Price
| Previous Close | $0.99 |
| Open | $1.00 |
| Day High | $1.06 |
| Day Low | $1.00 |
| Volume | 173,079 |
Stock Information
| Shares Outstanding | 44.21M |
| Total Debt | $4.22M |
| Cash Equivalents | $28.49M |
| Revenue | $12.46M |
| Net Income | $-21.88M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $46.86M |
| EPS (TTM) | $-0.66 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $21.31M |
| Sales | $12.46M |
| Income | $-21.88M |
| Book/sh | $0.52 |
| Cash/sh | $0.64 |
| Employees | 25 |
Financial Ratios
| Quick Ratio | 1.29 |
| Current Ratio | 2.05 |
| Debt/Eq | 18.73 |
Returns & Margins
| ROA | -26.39% |
| Gross Margin | 56.33% |
| Operating Margin | -184.39% |
| Profit Margin | 400.16% |
Ownership
| Insider Ownership | 3.48% |
| Institutional Ownership | 45.72% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.96 |
| P/S | 3.76 |
| P/B | 2.02 |
Analyst Data
| Recommendation | none |
| Target Price | $5.00 |
Technical Indicators
| SMA20 | $1.05 |
| SMA50 | $1.06 |
| SMA200 | $0.97 |
| RSI | 41.72 |
| ATR | 0.0806 |
| Shares Float | 25.02M |
| Short Float | 0.11% |
| Short Ratio | 0.29 |
| Rel Volume | 1.66 |
Performance History
| Week | +10.76% |
| Month | -5.36% |
| Quarter | +0.95% |
| 6 Months | +94.50% |
| YTD | +64.85% |
| Year | -40.11% |
| 3 Years | -56.02% |
| 5 Years | -89.99% |
| 10 Years | -92.69% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.06 | 173,000 |
| 2026-06-17 | $0.99 | 26,800 |
| 2026-06-16 | $0.95 | 82,000 |
| 2026-06-15 | $0.97 | 88,100 |
| 2026-06-12 | $0.96 | 79,500 |
| 2026-06-11 | $0.96 | 163,000 |
| 2026-06-10 | $1.04 | 118,700 |
| 2026-06-09 | $0.97 | 61,500 |
| 2026-06-08 | $0.99 | 24,400 |
| 2026-06-05 | $1.00 | 57,400 |
| 2026-06-04 | $1.05 | 219,500 |
| 2026-06-03 | $0.99 | 145,700 |
| 2026-06-02 | $1.04 | 48,500 |
| 2026-06-01 | $1.06 | 235,800 |
| 2026-05-29 | $1.16 | 75,000 |
| 2026-05-28 | $1.12 | 47,600 |
| 2026-05-27 | $1.13 | 31,000 |
| 2026-05-26 | $1.14 | 39,400 |
| 2026-05-22 | $1.16 | 307,500 |
| 2026-05-21 | $1.20 | 64,400 |
| 2026-05-20 | $1.18 | 121,800 |
| 2026-05-19 | $1.12 | 145,300 |
About Elutia Inc.
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.
đ° Latest News
Elutia (ELUT) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-15T12:58:03Z
Elutia Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-15T12:30:00Z
Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue Shifts
GuruFocus.com âĸ 2026-05-15T05:01:12ZElutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Moves Amid ...
GuruFocus.com âĸ 2026-03-12T03:00:51ZElutia Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-12T00:18:52Z
Elutia (ELUT) Q4 2025 Earnings Call Transcript
Motley Fool âĸ 2026-03-11T22:47:50Z
Insider Spends US$74k Buying More Shares In Elutia
Simply Wall St. âĸ 2026-02-04T10:52:33Z
ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know
Zacks âĸ 2025-12-31T17:00:05Z
How The BioEnvelope Sale Is Changing Elutiaâs Story and Shaping Its Future Valuation
Simply Wall St. âĸ 2025-12-02T16:08:00Z
M&A Strategy Strengthens Boston Scientific's Growth Prospects
Zacks âĸ 2025-12-02T12:56:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $5,697,000 | $7,752,000 | $13,692,000 | $12,210,000 |
| Cost Of Revenue | $5,697,000 | $7,752,000 | $13,692,000 | $12,210,000 |
| Total Revenue | $12,293,000 | $14,467,000 | $24,745,000 | $23,849,000 |
| Operating Revenue | $12,293,000 | $14,467,000 | $24,745,000 | $23,849,000 |
| Expenses | ||||
| Total Expenses | $30,705,000 | $33,811,000 | $45,282,000 | $53,838,000 |
| Other Income Expense | $2,167,000 | $-25,060,000 | $-14,888,000 | $-1,041,000 |
| Other Non Operating Income Expenses | $-2,758,000 | $1,186,000 | $-759,000 | $4,159,000 |
| Net Non Operating Interest Income Expense | $400,000 | $-900,000 | $-5,796,000 | $-5,118,000 |
| Operating Expense | $25,008,000 | $26,059,000 | $31,590,000 | $41,628,000 |
| Selling And Marketing Expense | $5,765,000 | $4,988,000 | $13,087,000 | $17,850,000 |
| General And Administrative Expense | $15,080,000 | $18,073,000 | $14,104,000 | $16,051,000 |
| Interest Expense | - | $900,000 | $5,796,000 | $5,118,000 |
| Interest Expense Non Operating | - | $900,000 | $5,796,000 | $5,118,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-15,871,000 | $-45,345,000 | $-41,249,000 | $-36,182,000 |
| Net Interest Income | $400,000 | $-900,000 | $-5,796,000 | $-5,118,000 |
| Interest Income | $400,000 | - | - | - |
| Normalized Income | $-19,761,750 | $-24,610,660 | $-30,087,090 | $-32,074,000 |
| Net Income From Continuing And Discontinued Operation | $53,380,000 | $-53,949,000 | $-37,656,000 | $-32,897,000 |
| Total Operating Income As Reported | $-26,911,000 | $-30,712,000 | $-30,526,000 | $-35,189,000 |
| Average Dilution Earnings | $-13,424,000 | $0 | - | - |
| Net Income Common Stockholders | $53,380,000 | $-53,949,000 | $-37,656,000 | $-32,897,000 |
| Net Income | $53,380,000 | $-53,949,000 | $-37,656,000 | $-32,897,000 |
| Net Income Including Noncontrolling Interests | $53,380,000 | $-53,949,000 | $-37,656,000 | $-32,897,000 |
| Net Income Discontinuous Operations | $69,251,000 | $-8,604,000 | $3,593,000 | $3,285,000 |
| Net Income Continuous Operations | $-15,871,000 | $-45,345,000 | $-41,249,000 | $-36,182,000 |
| Pretax Income | $-15,858,000 | $-45,338,000 | $-41,221,000 | $-36,148,000 |
| Special Income Charges | $-8,499,000 | $-11,368,000 | $-9,989,000 | $-5,200,000 |
| Interest Income Non Operating | $400,000 | - | - | - |
| Operating Income | $-18,412,000 | $-19,344,000 | $-20,537,000 | $-29,989,000 |
| Gross Profit | $6,596,000 | $6,715,000 | $11,053,000 | $11,639,000 |
| Per Share | ||||
| Diluted EPS | $0.87 | $-1.86 | $-2.07 | $-2.38 |
| Basic EPS | $1.29 | $-1.86 | $-2.07 | $-2.38 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,034,250 | $-5,511,660 | $-2,967,090 | $-1,092,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-20,552,000 | $-14,741,000 | $-17,548,000 | $-22,097,000 |
| Total Unusual Items | $4,925,000 | $-26,246,000 | $-14,129,000 | $-5,200,000 |
| Total Unusual Items Excluding Goodwill | $4,925,000 | $-26,246,000 | $-14,129,000 | $-5,200,000 |
| Reconciled Depreciation | $2,785,000 | $3,451,000 | $3,748,000 | $3,733,000 |
| EBITDA (Bullshit earnings) | $-15,627,000 | $-40,987,000 | $-31,677,000 | $-27,297,000 |
| EBIT | $-18,412,000 | $-44,438,000 | $-35,425,000 | $-31,030,000 |
| Diluted Average Shares | $45,942,787 | $29,071,113 | $18,160,822 | $13,832,887 |
| Basic Average Shares | $41,416,850 | $29,071,113 | $18,160,822 | $13,832,887 |
| Diluted NI Availto Com Stockholders | $39,956,000 | $-53,949,000 | $-37,656,000 | $-32,897,000 |
| Tax Provision | $13,000 | $7,000 | $28,000 | $34,000 |
| Other Special Charges | $8,499,000 | $11,368,000 | $9,989,000 | $5,200,000 |
| Gain On Sale Of Security | $13,424,000 | $-14,878,000 | $-4,140,000 | - |
| Research And Development | $4,163,000 | $2,998,000 | $4,399,000 | $7,727,000 |
| Selling General And Administration | $20,845,000 | $23,061,000 | $27,191,000 | $33,901,000 |
| Other Gand A | $15,080,000 | $18,073,000 | $14,104,000 | $16,051,000 |
| Otherunder Preferred Stock Dividend | - | - | - | - |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $26,143,000 | $-48,860,000 | $-50,271,000 | $-20,102,000 |
| Total Assets | $62,350,000 | $36,127,000 | $43,428,000 | $68,841,000 |
| Total Non Current Assets | $6,532,000 | $9,955,000 | $12,175,000 | $18,142,000 |
| Goodwill And Other Intangible Assets | $1,529,000 | $2,600,000 | $11,671,000 | $15,069,000 |
| Other Intangible Assets | $1,529,000 | $2,600,000 | $11,671,000 | $15,069,000 |
| Current Assets | $55,818,000 | $26,172,000 | $31,253,000 | $50,699,000 |
| Other Current Assets | $2,271,000 | $1,986,000 | $2,165,000 | $2,387,000 |
| Assets Held For Sale Current | $0 | $1,980,000 | $0 | $9,496,000 |
| Inventory | $2,617,000 | $1,931,000 | $3,853,000 | $4,240,000 |
| Receivables | $14,580,000 | $7,036,000 | $5,959,000 | $17,587,000 |
| Other Receivables | $12,846,000 | $4,760,000 | $2,696,000 | $13,813,000 |
| Accounts Receivable | $1,734,000 | $2,276,000 | $3,263,000 | $3,774,000 |
| Allowance For Doubtful Accounts Receivable | $-200,000 | $-600,000 | $-700,000 | $-100,000 |
| Gross Accounts Receivable | $1,934,000 | $2,876,000 | $3,963,000 | $3,874,000 |
| Cash Cash Equivalents And Short Term Investments | $36,350,000 | $13,239,000 | $19,276,000 | $16,989,000 |
| Cash And Cash Equivalents | $36,350,000 | $13,239,000 | $19,276,000 | $16,989,000 |
| Other Non Current Assets | - | $6,505,000 | - | $2,508,000 |
| Restricted Cash | - | - | - | $0 |
| Cash Financial | - | - | - | $16,989,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $3,942,000 | $24,014,000 | $23,952,000 | $24,492,000 |
| Long Term Debt And Capital Lease Obligation | $3,587,000 | $22,619,000 | $20,356,000 | $24,260,000 |
| Current Debt And Capital Lease Obligation | $355,000 | $1,395,000 | $3,596,000 | $232,000 |
| Net Debt | - | $10,614,000 | $4,401,000 | $7,271,000 |
| Long Term Debt | - | $22,603,000 | $20,356,000 | $24,260,000 |
| Current Debt | - | $1,250,000 | $3,321,000 | - |
| Other Current Borrowings | - | $1,250,000 | $3,321,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $34,678,000 | $82,387,000 | $82,028,000 | $73,874,000 |
| Total Non Current Liabilities Net Minority Interest | $9,539,000 | $44,592,000 | $38,991,000 | $31,259,000 |
| Other Non Current Liabilities | $2,828,000 | $5,490,000 | $5,875,000 | $6,043,000 |
| Liabilities Heldfor Sale Non Current | $0 | $407,000 | $0 | $956,000 |
| Derivative Product Liabilities | $3,124,000 | $16,076,000 | $12,760,000 | $0 |
| Current Liabilities | $25,139,000 | $37,795,000 | $43,037,000 | $42,615,000 |
| Other Current Liabilities | $15,641,000 | $25,147,000 | $26,765,000 | $31,279,000 |
| Payables And Accrued Expenses | $9,143,000 | $11,253,000 | $12,676,000 | $11,104,000 |
| Payables | $4,791,000 | $4,149,000 | $3,191,000 | $2,274,000 |
| Accounts Payable | $4,791,000 | $4,149,000 | $3,191,000 | $1,374,000 |
| Other Payable | - | - | $906,000 | $900,000 |
| Non Current Deferred Liabilities | - | - | - | - |
| Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $27,672,000 | $-46,260,000 | $-38,600,000 | $-5,033,000 |
| Total Equity Gross Minority Interest | $27,672,000 | $-46,260,000 | $-38,600,000 | $-5,033,000 |
| Stockholders Equity | $27,672,000 | $-46,260,000 | $-38,600,000 | $-5,033,000 |
| Retained Earnings | $-176,213,000 | $-229,593,000 | $-175,644,000 | $-137,988,000 |
| Other | ||||
| Ordinary Shares Number | $42,784,848 | $35,210,638 | $23,197,602 | $11,823,445 |
| Share Issued | $42,784,848 | $35,210,638 | $23,197,602 | $11,823,445 |
| Tangible Book Value | $26,143,000 | $-48,860,000 | $-50,271,000 | $-20,102,000 |
| Invested Capital | $27,672,000 | $-22,407,000 | $-14,923,000 | $19,227,000 |
| Working Capital | $30,679,000 | $-11,623,000 | $-11,784,000 | $8,084,000 |
| Capital Lease Obligations | $3,942,000 | $161,000 | $275,000 | $232,000 |
| Total Capitalization | $27,672,000 | $-23,657,000 | $-18,244,000 | $19,227,000 |
| Additional Paid In Capital | $203,842,000 | $183,298,000 | $137,021,000 | $132,939,000 |
| Capital Stock | $43,000 | $35,000 | $23,000 | $16,000 |
| Common Stock | $43,000 | $35,000 | $23,000 | $16,000 |
| Long Term Capital Lease Obligation | $3,587,000 | $16,000 | $0 | $956,000 |
| Current Capital Lease Obligation | $355,000 | $145,000 | $275,000 | $232,000 |
| Current Accrued Expenses | $4,352,000 | $7,104,000 | $9,485,000 | $8,830,000 |
| Net PPE | $5,003,000 | $850,000 | $504,000 | $565,000 |
| Accumulated Depreciation | $-283,000 | $-221,000 | $-581,000 | $-585,000 |
| Gross PPE | $5,286,000 | $1,071,000 | $1,085,000 | $1,150,000 |
| Leases | $43,000 | $96,000 | $92,000 | $613,000 |
| Construction In Progress | $1,363,000 | $0 | - | - |
| Other Properties | $3,777,000 | $852,000 | $713,000 | $-680,000 |
| Machinery Furniture Equipment | $103,000 | $123,000 | $280,000 | $1,217,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $2,378,000 | $1,863,000 | $3,325,000 | $3,047,000 |
| Raw Materials | $239,000 | $68,000 | $242,000 | $652,000 |
| Work In Process | - | $740,000 | $286,000 | $541,000 |
| Line Of Credit | - | - | - | $0 |
| Non Current Deferred Revenue | - | - | - | - |
| Current Deferred Revenue | - | - | - | - |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-46,686,000 | $-23,311,000 | $-22,107,000 | $-21,974,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-44,810,000 | $-22,657,000 | $-21,761,000 | $-21,434,000 |
| Cash Flow From Continuing Operating Activities | $-44,810,000 | $-22,657,000 | $-21,761,000 | $-21,434,000 |
| Operating Gains Losses | $-92,348,000 | $14,698,000 | $-3,389,000 | $311,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,876,000 | $-654,000 | $-346,000 | $-540,000 |
| Investing Cash Flow | $78,559,000 | $-474,000 | $14,208,000 | $-540,000 |
| Cash Flow From Continuing Investing Activities | $78,559,000 | $-474,000 | $14,208,000 | $-540,000 |
| Capital Expenditure Reported | $-1,876,000 | $-654,000 | $-346,000 | $-540,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $13,795,000 | $12,390,000 | $10,085,000 | $10,089,000 |
| Financing Cash Flow | $-10,638,000 | $17,094,000 | $9,840,000 | $8,535,000 |
| Cash Flow From Continuing Financing Activities | $-10,638,000 | $17,094,000 | $9,840,000 | $8,535,000 |
| Net Other Financing Charges | $-1,481,000 | $-9,183,000 | $1,491,000 | $-3,571,000 |
| Net Common Stock Issuance | $13,795,000 | $12,390,000 | $10,085,000 | $10,089,000 |
| Common Stock Issuance | $13,795,000 | $12,390,000 | $10,085,000 | $10,089,000 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Interest Paid Supplemental Data | $7,492,000 | $5,288,000 | $2,321,000 | $5,480,000 |
| End Cash Position | $36,350,000 | $13,239,000 | $19,276,000 | $16,989,000 |
| Beginning Cash Position | $13,239,000 | $19,276,000 | $16,989,000 | $30,428,000 |
| Changes In Cash | $23,111,000 | $-6,037,000 | $2,287,000 | $-13,439,000 |
| Proceeds From Stock Option Exercised | $112,000 | $15,887,000 | $219,000 | $395,000 |
| Net Issuance Payments Of Debt | $-23,064,000 | $-2,000,000 | $-1,955,000 | $1,622,000 |
| Net Long Term Debt Issuance | $-23,064,000 | $-2,000,000 | $-1,955,000 | $6,385,000 |
| Net Business Purchase And Sale | $80,435,000 | $180,000 | $14,554,000 | $0 |
| Sale Of Business | $80,435,000 | $180,000 | $14,554,000 | $0 |
| Change In Working Capital | $-16,534,000 | $2,943,000 | $6,959,000 | $5,711,000 |
| Change In Other Current Liabilities | $-8,059,000 | $4,943,000 | $-2,406,000 | $16,789,000 |
| Change In Payables And Accrued Expense | $-6,547,000 | $-1,148,000 | $-2,113,000 | $5,593,000 |
| Change In Prepaid Assets | $-285,000 | $743,000 | $167,000 | $-1,526,000 |
| Change In Inventory | $-1,641,000 | $-58,000 | $-609,000 | $-498,000 |
| Change In Receivables | $-2,000 | $-1,537,000 | $11,920,000 | $-14,647,000 |
| Changes In Account Receivables | $84,000 | $527,000 | $802,000 | $-834,000 |
| Other Non Cash Items | $2,235,000 | $1,849,000 | $5,550,000 | $-1,939,000 |
| Stock Based Compensation | $5,214,000 | $7,891,000 | $2,437,000 | $3,647,000 |
| Asset Impairment Charge | $458,000 | $460,000 | $590,000 | $0 |
| Depreciation Amortization Depletion | $2,785,000 | $3,451,000 | $3,748,000 | $3,733,000 |
| Depreciation And Amortization | $2,785,000 | $3,451,000 | $3,748,000 | $3,733,000 |
| Gain Loss On Investment Securities | $-13,424,000 | $14,878,000 | $4,140,000 | - |
| Gain Loss On Sale Of Business | $-80,211,000 | $-180,000 | $-7,529,000 | $0 |
| Net Income From Continuing Operations | $53,380,000 | $-53,949,000 | $-37,656,000 | $-32,897,000 |
| Repayment Of Debt | - | - | $0 | $-4,763,000 |
| Net Short Term Debt Issuance | - | - | $0 | $-4,763,000 |
| Short Term Debt Payments | - | - | $0 | $-4,763,000 |
| Change In Other Working Capital | - | - | $-70,000 | $-571,000 |
| Issuance Of Debt | - | - | - | $25,000,000 |
| Long Term Debt Payments | - | - | - | $-18,615,000 |
| Long Term Debt Issuance | - | - | - | $25,000,000 |
Fetched: 2026-06-19